mechanism of action of glp-1 receptor agonist Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review What is GLP-1 and Its

Published May 31, 2023

10.1517/17425255.2012.686603 166 ScheenA

Shortages occurred as demand outpaced supply from traditional pharmaceutical manufacturers

B., & Torekov, S

While patients living with chronic life-threatening conditions like Type 2 diabetes may accept these risks, people using GLP-1 drugs for less life-threatening and severe purposes like obesity may be less forgiving if the side effects outweigh the perceived benefits

In the 1990s, exendin-4, a GLP-1 receptor agonist (GLP-1 RA) structurally similar to endogenous GLP-1, was isolated from Gila monster venom, which subsequently led to the approval of exenatide for type 2 diabetes mellitus (T2DM) management in 2005 [2]